Stereotaxis Inc Stock Nasdaq
Equities
US85916J4094
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 30.88M | Sales 2025 * | 44.25M | Capitalization | 205M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -16M | EV / Sales 2024 * | 6.65 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.64 x |
P/E ratio 2024 * |
-10.6
x | P/E ratio 2025 * |
-13.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.12% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 16-09-28 | |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 02-12-31 |
Laura Garth
LAW | General Counsel | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 05-04-30 |
Chief Executive Officer | 57 | 16-09-28 | |
Nathan Fischel
BRD | Director/Board Member | 68 | 17-02-02 |
1st Jan change | Capi. | |
---|---|---|
+3.31% | 209B | |
+2.05% | 175B | |
+9.36% | 131B | |
+17.66% | 99.98B | |
-2.17% | 61.12B | |
+14.05% | 52.34B | |
-4.15% | 46.5B | |
-3.68% | 39.24B | |
+9.04% | 38.47B |